Group One Trading
INMB icon

Group One Trading’s INmune Bio INMB Stock Holding History

Group One Trading’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,200
Closed -$20.6K – 8139
2025
Q4 		$20.6K Sell
13,200
-204,100
-94% -$364K ﹤0.01% 6320
2025
Q3 		$450K Buy
217,300
+72,200
+50% +$165K ﹤0.01% 3813
2025
Q2 		$335K Buy
145,100
+111,300
+329% +$817K ﹤0.01% 3809
2025
Q1 		$264K Sell
33,800
-32,700
-49% -$260K ﹤0.01% 3733
2024
Q4 		$311K Buy
66,500
+11,300
+20% +$58.9K ﹤0.01% 3555
2024
Q3 		$298K Buy
55,200
+54,200
+5,420% +$385K ﹤0.01% 3276
2024
Q2 		$8.82K Sell
1,000
-3,300
-77% -$32.5K ﹤0.01% 5694
2024
Q1 		$50.5K Buy
4,300
+4,100
+2,050% +$49.5K ﹤0.01% 4710
2023
Q4 		$2.25K Sell
200
-600
-75% -$5.03K ﹤0.01% 6786
2023
Q3 		$5.47K Sell
800
-22,800
-97% -$189K ﹤0.01% 6657
2023
Q2 		$214K Buy
23,600
+21,100
+844% +$169K ﹤0.01% 3852
2023
Q1 		$16.1K Sell
2,500
-13,100
-84% -$106K ﹤0.01% 5651
2022
Q4 		$98.9K Buy
15,600
+12,300
+373% +$87.3K ﹤0.01% 4457
2022
Q3 		$20K Sell
3,300
-16,600
-83% -$146K ﹤0.01% 6074
2022
Q2 		$176K Buy
19,900
+15,200
+323% +$113K ﹤0.01% 4416
2022
Q1 		$40K Sell
4,700
-2,300
-33% -$20.7K ﹤0.01% 6272
2021
Q4 		$71K Buy
7,000
+3,400
+94% +$50.3K ﹤0.01% 6037
2021
Q3 		$70K Buy
3,600
+3,400
+1,700% +$65.7K ﹤0.01% 6258
2021
Q2 		$4K Buy
+200
New +$2.69K ﹤0.01% 7812

Other funds holding INMB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Group One Trading's INMB Position: Q2 2026 in Review

Group One Trading increased its INmune Bio (INMB) stake by 27% in Q2 2026, buying an estimated $145 and bringing the position to 493 shares worth $804. The position accounts for ﹤0.01% of the portfolio, ranked #7219.

Group One Trading first reported a position in INMB in Q2 2021 and has held it in 15 quarters since. The position peaked at $346K in Q3 2021. 82 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

  • Group One Trading held 493 shares of INmune Bio worth $804 as of Q2 2026.
  • Group One Trading bought 105 INmune Bio shares in Q2 2026, an estimated $145.
  • INmune Bio made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7219 holding.
  • Group One Trading first reported a position in INmune Bio in Q2 2021 and has held it in 15 quarters since.
  • Group One Trading's INmune Bio position peaked at $346K in Q3 2021.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.